4LiY BergQ FuZ.Effects of glibenclamide on mRNA level of ATP-sensitive potassium channels of heart in normal and streptozotocin—induced diabetic rats[J].Chinese Medical Journal（中华医学杂志：英文版）,2000,80(7):538-540.
6Reis AF, Velho G. Sulfonylurea receptor-1 (SUR1):genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus [ J ]. Diabetes Metab,2002,28(1) :14- 19.
7Hart LM,Dekker JM,Van Haeften TW,et al. Reduced second phase insulin secretion in carriers of a sulfonylurea receptor gene variant associating with type 2 diabetes mellitus[J]. Diabetologia, 2000,43 (4) :515 - 519.
8Elbein SC, Sun J, Scroggin E, et al. Role of common sequence variant in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear fimtor 1 alpha genes [J]. Diabetes Care, 2001,24 (3) :472-478.
9Weisnagd SJ, Rankinen T, Nadeau A, et al. Decreased fasting and oral glucose stimulated C-peptide in nondiabetic subjects with sequence variants in the sulfonylurea receptor 1 gene[J]. Diabetes, 2001,50(3) :697 - 702.
10Rissannen J,Markkanen A,Karkkainen P, et al. Sulfonyturea receptce-1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secreticn of insulin[J], Diabetes Care,2000,23(1) :70 - 73.
4P. J. Bijlstra,J. A. Lutterman,F. G. M. Russel,T. Thien,Professor P. Smits. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans[J] 1996,Diabetologia(9):1083～1090
5Walter Mertz. Chromium[J] 1992,Biological Trace Element Research(1-3):3～8
